Home>
US Stocks>
Twist Bioscience Corp

Twist Bioscience Corp share price today

(TWST)

Twist Bioscience Corp share price is $52.7 & ₹4,463.16 as on 7 Dec 2024, 2.30 'hrs' IST

$52.7

▲

1.96

(3.86%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Twist Bioscience Corp share price in Dollar and Rupees. Guide to invest in Twist Bioscience Corp from India. Also see the sentimental analysis on Indian investors investing in Twist Bioscience Corp. Get details on the Indian mutual funds that are investing in Twist Bioscience Corp. Get Analyst recommendations and forecasts along with all the Twist Bioscience Corp's financials.

Twist Bioscience Corp share price movements

$51.50
$53.59
$52.70
2.29%
Downside
Day's Volatility :3.9%
Upside
1.65%
$24.81
$60.90
$52.70
52.92%
Downside
52 Weeks Volatility :59.26%
Upside
13.46%

Twist Bioscience Corp Returns

Period	Twist Bioscience Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	36.18%	-5.7%	0.0%
6 Months	1.46%	-0.9%	0.0%
1 Year	81.86%	9.9%	0.0%
3 Years	-38.94%	8.4%	-22.1%

Twist Bioscience Corp Key Statistics

in dollars & INR

Previous Close	$50.74
Open	$51.48
Today's High	$53.585
Today's Low	$51.495
Market Capitalization	$2.9B
Today's Volume	$649.3K
52 Week High	$60.9
52 Week Low	$24.8101
Revenue TTM	$295.2M
EBITDA	$-156.7M
Earnings Per Share (EPS)	$-3.6
Profit Margin	-74.63%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-38.36%

How to invest in Twist Bioscience Corp from India?

It is very easy for Indian residents to invest directly in Twist Bioscience Corp from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Twist Bioscience Corp stock in both rupees (INR) and dollars (USD). Search for Twist Bioscience Corp or TWST on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Twist Bioscience Corp or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Twist Bioscience Corp shares which would translate to 0.016 fractional shares of Twist Bioscience Corp as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Twist Bioscience Corp

347%

Period: Sep 9, 2024 to Dec 8, 2024. Change in 30 Days versus previous period

Search volume for Twist Bioscience Corp on INDmoney from India has grown in the last 30 days as on Dec 9, 2024. 347% more investors are searching Twist Bioscience Corp in the last 30 days versus the previous period.

Global Institutional Holdings in Twist Bioscience Corp

Artisan Partners Limited Partnership
10.14%
Vanguard Group Inc
9.46%
BlackRock Inc
9.14%
ARK Investment Management LLC
9.03%
Amvescap Plc.
6.14%
William Blair Investment Management, LLC
5.86%

Analyst Recommendation on Twist Bioscience Corp

Buy

81%Buy

12%Hold

6%Sell

Based on 16 Wall street analysts offering stock ratings for Twist Bioscience Corp(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Twist Bioscience Corp

What analysts predicted

Downside of 4.19%

Current:

$52.70

Target:

$50.49

Insights on Twist Bioscience Corp

Increasing Revenue
Revenue is up for the last 8 quarters, 54.24M → 84.71M (in $), with an average increase of 6.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -85.57M → -34.65M (in $), with an average increase of 146.9% per quarter
Vs A
In the last 3 years, Twist Bioscience Corp has experienced a drawdown of -43.7%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 31.9%

Twist Bioscience Corp Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$54.4M	↑ 113.89%
Net Income	$-107.7M	↑ 51.14%
Net Profit Margin	-197.98%	↑ 82.18%

	FY20	Y/Y Change
Revenue	$90.1M	↑ 65.67%
Net Income	$-139.9M	↑ 29.96%
Net Profit Margin	-155.31%	↑ 42.67%

	FY21	Y/Y Change
Revenue	$132.3M	↑ 46.87%
Net Income	$-152.1M	↑ 8.69%
Net Profit Margin	-114.94%	↑ 40.37%

	FY22	Y/Y Change
Revenue	$203.6M	↑ 53.83%
Net Income	$-217.9M	↑ 43.24%
Net Profit Margin	-107.02%	↑ 7.92%

	FY23	Y/Y Change
Revenue	$245.1M	↑ 20.41%
Net Income	$-204.6M	↓ 6.08%
Net Profit Margin	-83.48%	↑ 23.54%

	FY24	Y/Y Change
Revenue	$313.0M	↑ 27.69%
Net Income	$-208.7M	↑ 2.01%
Net Profit Margin	-66.69%	↑ 16.79%

	Q2 FY23	Q/Q Change
Revenue	$63.7M	↑ 5.92%
Net Income	$-57.4M	↓ 2.98%
Net Profit Margin	-90.05%	↑ 8.25%

	Q3 FY23	Q/Q Change
Revenue	$66.9M	↑ 5.03%
Net Income	$-46.2M	↓ 19.43%
Net Profit Margin	-69.08%	↑ 20.97%

	Q4 FY23	Q/Q Change
Revenue	$71.5M	↑ 6.8%
Net Income	$-43.0M	↓ 7.0%
Net Profit Margin	-60.15%	↑ 8.93%

	Q1 FY24	Q/Q Change
Revenue	$75.3M	↑ 5.32%
Net Income	$-45.5M	↑ 5.78%
Net Profit Margin	-60.41%	↓ 0.26%

	Q2 FY24	Q/Q Change
Revenue	$81.5M	↑ 8.18%
Net Income	$-85.6M	↑ 88.1%
Net Profit Margin	-105.04%	↓ 44.63%

	Q3 FY24	Q/Q Change
Revenue	$84.7M	↑ 3.98%
Net Income	$-34.7M	↓ 59.5%
Net Profit Margin	-40.91%	↑ 64.13%

	FY19	Y/Y Change
Total Assets	$187.0M	↑ 61.49%
Total Liabilities	$34.9M	↓ 88.99%

	FY20	Y/Y Change
Total Assets	$398.9M	↑ 113.31%
Total Liabilities	$62.6M	↑ 79.37%

	FY21	Y/Y Change
Total Assets	$702.1M	↑ 76.02%
Total Liabilities	$121.3M	↑ 93.67%

	FY22	Y/Y Change
Total Assets	$961.4M	↑ 36.93%
Total Liabilities	$172.0M	↑ 41.82%

	FY23	Y/Y Change
Total Assets	$776.4M	↓ 19.24%
Total Liabilities	$153.0M	↓ 11.06%

	FY24	Y/Y Change
Total Assets	$614.3M	↓ 20.88%
Total Liabilities	$141.6M	↓ 7.41%

	Q2 FY23	Q/Q Change
Total Assets	$810.3M	↓ 5.1%
Total Liabilities	$152.8M	↑ 1.86%

	Q3 FY23	Q/Q Change
Total Assets	$776.4M	↓ 4.19%
Total Liabilities	$153.0M	↑ 0.12%

	Q4 FY23	Q/Q Change
Total Assets	$732.8M	↓ 5.61%
Total Liabilities	$142.8M	↓ 6.67%

	Q1 FY24	Q/Q Change
Total Assets	$702.8M	↓ 4.09%
Total Liabilities	$142.7M	↓ 0.04%

	Q2 FY24	Q/Q Change
Total Assets	$638.1M	↓ 9.21%
Total Liabilities	$147.0M	↑ 2.99%

	Q3 FY24	Q/Q Change
Total Assets	$614.3M	↓ 3.73%
Total Liabilities	$141.6M	↓ 3.64%

	FY19	Y/Y Change
Operating Cash Flow	$-87.9M	↑ 32.91%
Investing Cash Flow	$-104.8M	↓ 483.84%
Financing Cash Flow	$158.6M	↑ 78.53%

	FY20	Y/Y Change
Operating Cash Flow	$-142.3M	↑ 61.77%
Investing Cash Flow	$-114.7M	↑ 9.39%
Financing Cash Flow	$303.7M	↑ 91.53%

	FY21	Y/Y Change
Operating Cash Flow	$-112.2M	↓ 21.1%
Investing Cash Flow	$156.2M	↓ 236.2%
Financing Cash Flow	$329.2M	↑ 8.38%

	FY22	Y/Y Change
Operating Cash Flow	$-124.4M	↑ 10.82%
Investing Cash Flow	$-232.9M	↓ 249.17%
Financing Cash Flow	$270.5M	↓ 17.82%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-23.4M	↓ 47.14%
Investing Cash Flow	$18.7M	↓ 54.64%
Financing Cash Flow	$-661.0K	↓ 143.34%

Twist Bioscience Corp Technicals Summary

Sell

Neutral

Buy

Twist Bioscience Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Twist Bioscience Corp Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Twist Bioscience Corp	7.32%	1.46%	81.86%	-38.94%	95.15%
Twist Bioscience Corp	-1.34%	-15.89%	-20.26%	-29.68%	70.69%
Twist Bioscience Corp	0.87%	3.64%	6.9%	-11.77%	65.27%
Twist Bioscience Corp	-5.6%	-10.43%	5.23%	-18.93%	63.75%
Twist Bioscience Corp	-7.14%	-13.9%	2.95%	-28.23%	52.25%
Twist Bioscience Corp	-8.8%	-7.37%	-7.57%	-26.04%	38.99%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Twist Bioscience Corp	NA	NA	NA	-3.44	-0.38	-0.16	NA	8.39
Twist Bioscience Corp	41.3	41.3	4.5	10.73	0.59	0.23	NA	19.72
Twist Bioscience Corp	31.62	31.62	2.38	5.24	0.25	0.08	0.01	20.53
Twist Bioscience Corp	32.68	32.68	1.99	21.69	0.13	0.05	0.0	128.08
Twist Bioscience Corp	42.91	42.91	3.04	7.5	0.08	0.04	0.0	71.03
Twist Bioscience Corp	26.66	26.66	1.05	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Twist Bioscience Corp	Buy	$2.9B	95.15%	NA	-74.63%
Twist Bioscience Corp	Buy	$35.0B	70.69%	41.3	22.53%
Twist Bioscience Corp	Buy	$40.0B	65.27%	31.62	21.75%
Twist Bioscience Corp	Buy	$199.2B	63.75%	32.68	14.48%
Twist Bioscience Corp	Buy	$164.6B	52.25%	42.91	16.39%
Twist Bioscience Corp	Buy	$36.9B	38.99%	26.66	9.17%

Twist Bioscience Corp Dividend announcements

Twist Bioscience Corp Earnings
Twist Bioscience Corp’s price-to-earnings ratio stands at None
Read More

About Twist Bioscience Corp

at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .

Organization	Twist Bioscience Corp
Employees	919
CEO	Dr. Emily Marine Leproust Ph.D.
Industry	Health Technology

Management People of Twist Bioscience Corp

Name	Title
Dr. Emily Marine Leproust Ph.D.	Co-Founder, Chairman & CEO
Dr. Patrick John Finn Ph.D.	President & COO
Ms. Paula Green	Senior Vice President of Human Resources
Dr. William Charles Banyai Ph.D.	Senior VP of Advanced Development, GM of Data Storage & Director
Mr. Adam Laponis	Chief Financial Officer
Mr. Robert F. Werner	VP & Chief Accounting Officer
Mr. Siyuan Chen	Chief Technology Officer
Dr. Aaron K. Sato Ph.D.	Chief Scientific Officer
Dr. Michael Fero Ph.D.	Chief Information Officer
Mr. Dennis Cho J.D.	Senior VP, Chief Legal Officer & Corporate Secretary

Important FAQs about investing in Twist Bioscience Corp from India :

What is Twist Bioscience Corp share price today?

Twist Bioscience Corp (TWST) share price today is $52.70.

Can Indians buy Twist Bioscience Corp shares?

Yes, Indians can invest in the Twist Bioscience Corp (TWST) from India.

With INDmoney, you can buy Twist Bioscience Corp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Twist Bioscience Corp at zero transaction cost.

How can I buy Twist Bioscience Corp shares from India?

It is very easy to buy Twist Bioscience Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Twist Bioscience Corp be purchased?

Yes, you can buy fractional shares of Twist Bioscience Corp with INDmoney app.

What are the documents required to start investing in Twist Bioscience Corp stocks?

To start investing in Twist Bioscience Corp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.